Prenetics Global Financials - Benzinga

Prenetics Global Ltd

PRENASDAQ

Trade with Public

Trade with Public

$18.85

0.090.48%

Last update: Aug 20, 12:16 PM

Earnings: Q2 2026 Earnings were released on Tue Aug 18th, before the market open

Conference Call: The most recent conference call started at 8:30 AM, 2 days ago

Click to view the webcast

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Prenetics Global Financials

Prenetics Global (PRE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Prenetics Global Sees FY2026 Sales $220.000M-$230.000M vs $214.071M Est

Prenetics Global (NASDAQ:PRE) sees FY2026 sales of $220.000 million-$230.000 million vs $214.071 million analyst estimate.

Benzinga Newsdesk

PRO
Prenetics Global Sees Q3 Sales $63.000M-$64.000M vs $59.310M Est

Prenetics Global (NASDAQ:PRE) sees Q3 sales of $63.000 million-$64.000 million vs $59.310 million analyst estimate.

Benzinga Newsdesk

PRO
Prenetics Global Initiates FY2027 guidance of $400 million+ in IM8 revenue

Prenetics Global (NASDAQ:PRE) initiates FY2027 guidance of $400 million+ in IM8 revenue.

Benzinga Newsdesk

PRO
Prenetics Global Q2 EPS $(0.53) Beats $(0.71) Estimate, Sales $46.488M Miss $48.920M Estimate

Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.71) by 25.35 percent. This is a 35.37 percent increase over losses of $(0.82) per share from

Benzinga Newsdesk

PRO
Prenetics Global Announces Closing Of $1B In Growth Financing From General Catalyst’s Customer Value Fund; Co. Raises FY26 IM8 Revenue Guidance To $210M-$220M, Up From $190M-$210M

IM8 is the fastest-growing premium supplement brand ever recorded — over 50 million servings delivered to date, with approximately 200,000 servings currently delivered daily, and an order every 27 secondsPrenetics

Benzinga Newsdesk

PRO
Prenetics Global Affirms Q2 Sales Guidance of $46.000M-$48.000M vs $37.849M Est

Prenetics Global (NASDAQ:PRE) affirms Q2 sales outlook from $46.000 million-$48.000 million to $46.000 million-$48.000 million vs $37.849 million estimate.

Benzinga Newsdesk